Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validating The Prognostic Role of ATR Mutation in Patients With Endometrioid Endometrial Cancer

NCT01208467 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT01208467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01208467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validating The Prognostic Role of ATR Mutation in Patients With Endometrioid Endometrial Cancer
Lead sponsor
Gynecologic Oncology Group
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
Not reported
Enrollment
2,824 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial adenocarcinoma, recurrent uterine corpus carcinoma, stage i uterine corpus cancer, stage ii uterine corpus cancer, stage iii uterine corpus cancer, stage iv uterine corpus cancer